BM

Brij Mohan Gandhi

Director Director DIN 00186866
DIN 00186866 First appointment Dec 2011 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2011
Shareholding value Locked Premium profile

About Brij Mohan Gandhi

Data last updated:

Brij Mohan Gandhi has 14 years in corporate governance. Formerly with 1 company, such as Emprocell Clinical Research Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00186866
Primary Designation Director
First Appointment 12 Dec 2011
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director12 Dec 20112006Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Emprocell Clinical Research Private Limited
Premium access

Shareholding and investment profile for Brij Mohan Gandhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Brij Mohan Gandhi

Brij Mohan Gandhi has 14 years in corporate governance. Formerly with 1 company, such as Emprocell Clinical Research Private Limited. Engaged in General Business. Contributes to corporate operations.

Brij Mohan Gandhi is associated with 0 companies as a director.

Brij Mohan Gandhi has expertise in General Business.

Brij Mohan Gandhi has 14 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available